| | | | | | What you need to know about the coronavirus today | When coronavirus and protests collide Australian authorities are taking legal action to try and stop a Black Lives Matter protest scheduled for Saturday in Sydney, citing the risk of an outbreak of COVID-19 given the thousands expected to attend. French police have also banned a demonstration planned for Saturday in front of the U.S. Embassy in Paris because of what they said were risks of social disorder and health dangers from large gatherings due to the coronavirus pandemic.
Hydroxychloroquine or not? An influential study that found hydroxychloroquine increased the risk of death in COVID-19 patients has been withdrawn a week after it led to major trials being halted, adding to confusion about a malaria drug championed by Donald Trump. The Lancet medical journal pulled the study after three of its authors retracted it, citing concerns about the quality and veracity of data in it.
Surging cases in Brazil, Mexico and India The number of coronavirus deaths in Brazil has blown past Italy's toll, while Mexico reported a record number of new cases, as regional leaders in Latin America push to end quarantine measures and kick their economies back into gear. The region as a whole has become a new focus of the coronavirus pandemic, with health officials urging governments there not to open their economies too fast and to avoid public crowds. India's coronavirus infections are meanwhile rising at the fastest daily rate than at any time in the past three months, but it plans to open shopping malls, restaurants and places of worship next week.
More drinkers cut than increase alcohol People missing out on drinking in restaurants and bars during coronavirus lockdowns are not entirely making up for it by pouring more at home, a survey of nine countries conducted on behalf of beer, wine and spirits companies showed. | | | | | | From Breakingviews - Corona Capital: Bank of England financing, China Nasdaq IPO. Concerns about the Bank of England’s corporate financing facility are misplaced, and a Chinese upstart makes the increasingly perilous journey to a U.S. listing. Catch up with the latest financial insights. | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | United States | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |